# Phase 2 COVID-19 trials recruiting: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 2 for COVID-19 that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 COVID-19 trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/covid-19

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07899346 | Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome | Invivyd, Inc. | Phase 2 | Not yet recruiting | Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine, COVID Long | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899346) |
| September 9, 2026 | NCT07808697 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to \<12 Years of Age | ModernaTX, Inc. | Phase 2 | Recruiting | SARS-CoV-2 | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808697) |
| June 4, 2026 | NCT07627815 | Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID | ParagonClinicals Inc. | Phase 2 | Recruiting | Long COVID | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627815) |
| February 12, 2026 | NCT07406217 | OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients | Sponsor not shown (see the record) | Phase 2 | Recruiting | COVID-19, Immunodeficiency | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07406217) |
| September 29, 2025 | NCT07197164 | Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Phase 2 | Recruiting | COVID - 19, Renal Transplant, SARS CoV 2 Infection | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07197164) |
| September 24, 2025 | NCT07189936 | Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS | Vanderbilt University Medical Center | Phase 2 | Recruiting | Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), SARS CoV 2 Infection, Long COVID19 | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189936) |
| July 28, 2025 | NCT07089719 | Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study) | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Dyspnea Caused by 2019-nCoV | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07089719) |
| September 19, 2024 | NCT06599658 | COVID-19 Booster and IIV Schedule in Immunocompromised Hosts | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 | Recruiting | COVID 19, Influenza, Rheumatoid Arthritis (RA), Systemic Lupus Erthematosus, Inflammatory Bowel Disease, Solid Organ... | 660 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06599658) |
| April 24, 2024 | NCT06381739 | A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol | McMaster University | Phase 2 | Recruiting | COVID-19 Infection | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06381739) |
| August 25, 2023 | NCT06012552 | Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in... | Military Institute od Medicine National Research Institute | Phase 2 | Recruiting | Nervous System Diseases | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06012552) |
| May 11, 2023 | NCT05855330 | Arginine Replacement Therapy in COVID-19 | Emory University | Phase 2 | Recruiting | COVID-19 | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05855330) |
| March 28, 2023 | NCT05787327 | RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19 | Chinese University of Hong Kong | Phase 2 | Recruiting | COVID-19 | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05787327) |
| October 20, 2022 | NCT05587894 | OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial | ANRS, Emerging Infectious Diseases | Phase 2 | Recruiting | COVID-19, Immunodeficiency | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05587894) |
| September 29, 2021 | NCT05060705 | "Efesovir" (FS-1) for COVID-19, Phase 2 | Scientific Center for Anti-infectious Drugs, Kazakhstan | Phase 2 | Not yet recruiting | Covid19 | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05060705) |
| September 13, 2021 | NCT05041907 | Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) | University of Oxford | Phase 2 | Recruiting | COVID-19 | 3,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05041907) |
| March 24, 2021 | NCT04815096 | Imaging Immune Activation in COVID-19 | CellSight Technologies, Inc. | Phase 2 | Recruiting | Covid19, SARS-CoV Infection | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04815096) |
| December 3, 2020 | NCT04652115 | Defibrotide for the Treatment of Severe COVID-19 | Brigham and Women's Hospital | Phase 2 | Recruiting | Covid19 | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04652115) |
| July 31, 2020 | NCT04494724 | Clazakizumab vs. Placebo - COVID-19 Infection | The Methodist Hospital Research Institute | Phase 2 | Recruiting | COVID-19 Infection | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04494724) |
| June 24, 2020 | NCT04445285 | Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure | Sponsor not shown (see the record) | Phase 2 | Recruiting | Covid19 | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04445285) |
| June 22, 2020 | NCT04442191 | Convalescent Plasma as a Possible Treatment for COVID-19 | University of Illinois Chicago | Phase 2 | Recruiting | COVID-19 | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04442191) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 1 |
| University of Oxford | 1 |
| Military Institute od Medicine National Research Institute | 1 |
| ANRS, Emerging Infectious Diseases | 1 |
| McMaster University | 1 |
| The Methodist Hospital Research Institute | 1 |
| Emory University | 1 |
| CellSight Technologies, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Brigham and Women's Hospital | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| University of Illinois Chicago | 1 |
| Vanderbilt University Medical Center | 1 |
| ParagonClinicals Inc. | 1 |
| Scientific Center for Anti-infectious Drugs, Kazakhstan | 1 |
| Chinese University of Hong Kong | 1 |
| [ModernaTX, Inc.](https://specstream.ai/data/clinical-trials/company/modernatx-inc) | 1 |
| Invivyd, Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 8 |
| Canada | 3 |
| France | 2 |
| Spain | 1 |
| Brazil | 1 |
| Laos | 1 |
| Nepal | 1 |
| Pakistan | 1 |
| Thailand | 1 |
| Poland | 1 |
| Italy | 1 |
| Norway | 1 |
| Kazakhstan | 1 |
| Switzerland | 1 |
| Hong Kong | 1 |
| Argentina | 1 |
| Dominican Republic | 1 |
| Mexico | 1 |
| Panama | 1 |
| Puerto Rico | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Lighting fixture manufacturers in the United States](https://specstream.ai/data/businesses/lighting-fixture-manufacturers/united-states)
- [Instrumentation engineers in the United States](https://specstream.ai/data/businesses/instrumentation-engineers/united-states)
- [Health food restaurants in the United States](https://specstream.ai/data/businesses/health-food-restaurants/united-states)
- [Flour mills in the United States](https://specstream.ai/data/businesses/flour-mills/united-states)
- [EMS training centers in the United States](https://specstream.ai/data/businesses/ems-training-centers/united-states)
- [Dental supply stores in the United States](https://specstream.ai/data/businesses/dental-supply-stores/united-states)
